Ask Me Anything
Featuring Dr. Matthew Davids and Doreen Zetterlund
Wednesday, July 12, 2023
10:30 – 11:30 AM PT / 11:30 AM -12:30 PM MT / 12:30 – 1:30 PM CT / 1:30 – 2:30 PM ET
(Duration 60 minutes)
Follow us on Facebook @CLLSociety and join the event live. Feel free to comment, ask questions, and react during the event!
Dr. Matthew Davids joins us for CLL Society’s Facebook Live Event “Ask Me Anything”. With no prepared presentation, this event is truly dedicated to answering your questions. Dr. Davids is the Associate Director, Center for Chronic Lymphocytic Leukemia at Dana Farber Cancer Institute and a Co-Chair of CLL Society’s Medical Advisory Board.
Fellow CLL patient advocate Doreen Zetterlund joins us to moderate this event. Doreen is a long-time supporter of the CLL / SLL community and a member of CLL Society’s Patient Advisory Board.
Two Ways to Join
We are offering registration for this event through Zoom to help with calendar and email reminders. You can watch the event through Zoom and ask questions, but we recommend watching the event on the Facebook Event page and ask questions, add comments in community with our audience on Facebook.
RSVP to the Facebook Event page to receive reminders via Facebook. Make sure to join us on CLL Society’s Facebook page on Wednesday, July 12th during your time zone, listed above to watch the event live.
Ask Questions in Advance
Ask your question in advance of the event by emailing [email protected] by July 10th. Please include “Facebook Live Question” in the subject line.
Questions asked in advance are provided to the speaker in preparation for the event. Questions that are applicable to more than one person and written more broadly have a higher chance of being asked by the moderator.
Matthew S. Davids, MD, MMSc
Associate Director, Center for Chronic Lymphocytic Leukemia
Dana Farber Cancer Institute
CLL / SLL Patient Advocate
Find CLL Society on Social Media
Follow CLL Society on Facebook @CLLSociety as well as other social media platforms below.
This program was made possible by generous donors and grant support from Astra Zeneca and BeiGene.